Searched for
DIVERSIFIED PRODUCT PORTFOLIO
Fibe parent files draft papers with Sebi for IPO; aims to garner Rs 750-cr via fresh issueDigital lending platform Fibe's parent company, Social Worth Technologies, is set to launch an Initial Public Offering (IPO). The company a...
Motilal Oswal initiates coverage on Tata Capital, gives target price and re-rating triggersMotilal Oswal has initiated coverage on Tata Capital with a 'Neutral' rating and a target price of Rs 390, implying an 8% upside from curre...
NRI Talk | Rupee depreciation shouldn't deter NRIs; India still offers attractive dollar returns: Feroze AzeezNRIs are questioning India's investment appeal due to recent flat returns and rupee depreciation. However, experts emphasize India's strong...
Oil cools, monsoon heats up concerns for India's rural economyThe recent drop in crude oil prices is providing some relief from inflation worries. Yet, the unpredictable monsoon season poses a serious ...
NRI Talk| For a Rs 50 crore NRI portfolio, structure matters as much as stock selection: Tarun BiraniNRIs view India with cautious optimism, recognizing its long-term growth potential despite recent market flatness and rupee depreciation. D...
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
ETMarkets Smart Talk | AI and semiconductors remain the best global investment themes today: Niteen DongareAs Indian investors increasingly diversify globally, AI and semiconductors remain the most compelling long-term investment themes, accordin...
ITC charts growth through FMCG, digital farming and fresh foodsITC Ltd is aggressively pursuing a medium-term growth strategy, aiming to become India's top FMCG player by bolstering core brands and expl...
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
Planning a Rs 7 crore corpus in 12 years? Expert recommends active funds over index fundsAn investor's query about active versus passive funds for long-term goals received expert advice. While index funds offer low costs, active...
Buy the dip, stay invested: Matt Orton sees more upside for global marketsGlobal markets are gaining traction as geopolitical worries ease and AI companies report strong earnings. Matt Orton of Raymond James highl...
FundsIndia raises Rs 44.6 crore through maiden secured NCD issueFundsIndia has raised Rs 44.6 crore through its maiden private placement of secured non-convertible debentures, marking its entry into the ...
NFO Insight: Can JM Multi Asset Allocation Fund help investors navigate uncertain market?JM Financial Mutual Fund has launched the JM Multi Asset Allocation Fund, aiming to provide long-term capital appreciation and income by in...
Sri Priyanka Geo Commex IPO opens for subscription today. Check GMP, price band and other detailsRetail investors can bid for a minimum of 1,200 shares, requiring an investment of Rs 2.54 lakh at the upper end of the price band. The min...
Dhanwel Hybrid Seeds IPO: GMP among key details to know before subscriptionThe Rs 26.73-crore IPO is entirely a fresh issue of 27 lakh equity shares and will remain open for subscription till June 29
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
Investors expecting 15-20% returns may be disappointed: Rajeev ThakkarInvestors should brace for lower nominal equity returns, as corporate profit growth moderates, according to PPFAS Mutual Fund's Rajeev Thak...
‘Markets will remain noisy. That’s how you make money’: Axis MF’s CEO & MD B. Gopkumar on SIPs, volatility and investingAxis Asset Management Company has navigated turbulent weather in the past few years, coming under regulatory scrutiny over a controversy in...
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
The problem with owning 13 mutual funds to reach Rs 4.67 crore goalAn investor's 13-mutual fund portfolio, aiming for Rs 4.67 crore, was deemed over-fragmented and style-overlapping. An expert advised conso...